ACXP
Acurx Pharmaceuticals LLC
NASDAQ: ACXP · HEALTHCARE · BIOTECHNOLOGY
$2.16
+0.00% today
Updated 2026-05-01
Market cap
$5.62M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.32
Dividend yield
—
52W range
$1 – $21
Volume
3.8M
Acurx Pharmaceuticals LLC (ACXP) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-77.4%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-93.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.6%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-5.2%
2025-11-18
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-13 | $-0.31 | +68.8% | $5.01 | $4.81 | -4.0% |
| 2025-11-18 | $-1.23 | -720.0% | $4.22 | $4.00 | -5.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.00 | $-0.31 | +68.8% | — | — |
| 2025-09-30 | $-0.15 | $-1.23 | -720.0% | — | — |
| 2025-06-30 | $-0.18 | $-1.89 | -950.0% | — | — |
| 2025-03-31 | $-0.14 | $-0.11 | +21.4% | — | — |
| 2024-12-31 | $-0.18 | $-0.16 | +11.1% | — | — |
| 2024-09-30 | $-0.20 | $-0.17 | +15.0% | — | — |
| 2024-06-30 | $-0.22 | $-0.26 | -18.2% | — | — |
| 2024-03-31 | $-0.24 | $-0.28 | -16.7% | — | — |
| 2023-12-31 | $-0.26 | $-0.37 | -42.3% | — | — |
| 2023-09-30 | $-0.27 | $-0.24 | +11.1% | — | — |
| 2023-06-30 | $-0.27 | $-0.28 | -3.7% | — | — |
| 2023-03-31 | $-0.29 | $-0.25 | +13.8% | — | — |
Frequently asked questions
Has Acurx Pharmaceuticals LLC beaten earnings estimates?
Acurx Pharmaceuticals LLC has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -77.4% over the last 4 quarters.
How does ACXP stock react to earnings?
ACXP stock has moved an average of -4.6% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.